These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 28484907)
1. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes. Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907 [TBL] [Abstract][Full Text] [Related]
2. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes. Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454 [TBL] [Abstract][Full Text] [Related]
3. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes. Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes. Kwon SS; Kim JH; Jeong HU; Cho YY; Oh SR; Lee HS Molecules; 2016 Apr; 21(5):. PubMed ID: 27128896 [TBL] [Abstract][Full Text] [Related]
5. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters. Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions. Liu S; Wang Z; Chan E; Zhao Y; Kang J; Zhang X; Tian X Chem Biol Interact; 2022 Jan; 352():109775. PubMed ID: 34910929 [TBL] [Abstract][Full Text] [Related]
7. In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters. Kim S; Choi WG; Kwon M; Lee S; Cho YY; Lee JY; Kang HC; Song IS; Lee HS Molecules; 2019 Aug; 24(16):. PubMed ID: 31430908 [TBL] [Abstract][Full Text] [Related]
8. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Jeong HU; Kong TY; Kwon SS; Hong SW; Yeon SH; Choi JH; Lee JY; Cho YY; Lee HS Molecules; 2013 Sep; 18(9):10681-93. PubMed ID: 24005963 [TBL] [Abstract][Full Text] [Related]
9. Mertansine Inhibits mRNA Expression and Enzyme Activities of Cytochrome P450s and Uridine 5'-Diphospho-Glucuronosyltransferases in Human Hepatocytes and Liver Microsomes. Choi WG; Park R; Kim DK; Shin Y; Cho YY; Lee HS Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32131538 [TBL] [Abstract][Full Text] [Related]
10. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro. Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effect of Selaginellins from Selaginella tamariscina (Beauv.) Spring against Cytochrome P450 and Uridine 5'-Diphosphoglucuronosyltransferase Isoforms on Human Liver Microsomes. Heo JK; Nguyen PH; Kim WC; Phuc NM; Liu KH Molecules; 2017 Sep; 22(10):. PubMed ID: 28934153 [No Abstract] [Full Text] [Related]
12. Effect of efavirenz on UDP-glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 activities in human liver microsomes. Ji HY; Lee H; Lim SR; Kim JH; Lee HS Molecules; 2012 Jan; 17(1):851-60. PubMed ID: 22252501 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition. Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066 [TBL] [Abstract][Full Text] [Related]
14. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. Nakashima A; Kawashita H; Masuda N; Saxer C; Niina M; Nagae Y; Iwasaki K Xenobiotica; 2005 Jun; 35(6):589-602. PubMed ID: 16192110 [TBL] [Abstract][Full Text] [Related]
15. Significantly decreased and more variable expression of major CYPs and UGTs in liver microsomes prepared from HBV-positive human hepatocellular carcinoma and matched pericarcinomatous tissues determined using an isotope label-free UPLC-MS/MS method. Yan T; Gao S; Peng X; Shi J; Xie C; Li Q; Lu L; Wang Y; Zhou F; Liu Z; Hu M Pharm Res; 2015 Mar; 32(3):1141-57. PubMed ID: 25288013 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry. Lee B; Ji HK; Lee T; Liu KH Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes. Kim JH; Kwon SS; Jeong HU; Lee HS Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305 [TBL] [Abstract][Full Text] [Related]
18. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar. Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778 [TBL] [Abstract][Full Text] [Related]
19. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases. Jin SE; Seo CS; Shin HK; Ha H Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264 [TBL] [Abstract][Full Text] [Related]
20. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes. Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]